Please Wait a Moment
X

CTS History

01Dec

Babesia

SuperUser Account |01 Dec, 2015 | Return|

In October, due to demand from existing healthcare partners, CTS began testing blood donors for antibody to Babesia microti under an Investigational New Drug exemption as a release test.

About the Author

Related

Source Plasma Testing

Source Plasma Testing

In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...

Read More >
On-time test results

On-time test results

Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...

Read More >
CTS merges with the three Red Cross testing laboratories

CTS merges with the three Red Cross testing laboratories

CTS merges with the three Red Cross testing laboratories located in Charlotte, Portland and St. Loui...

Read More >
Implementation of a COVID-19 Test

Implementation of a COVID-19 Test

CTS Tampa lab implemented the Ortho Clinical Diagnostics VITROS® testing platform to perform COVID-1...

Read More >
Source plasma partners

Source plasma partners

By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...

Read More >
Zika Testing

Zika Testing

In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...

Read More >